A Study to Determine the Effect of a High-Fat Meal on the Rate and Extent of E2006 Absorption in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2014
Price : $35 *
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 15 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Apr 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.
- 31 Mar 2014 Planned End Date changed from 1 Apr 2014 to 1 Jun 2014, as per ClinicalTrials.gov record.